Samuel Chapin - PerkinElmer Independent Director
| PKIDelisted Stock | USD 115.24 0.74 0.64% |
Director
Mr. Samuel R. Chapin serves as Independent Director of the Company. Mr. Chapin was appointed Executive Vice Chairman of Global Corporationrationrate Investment Banking at Bank of America Merrill Lynch in February 2010, where he was responsible for managing relationships with some of the firms largest clients. Mr. Chapin retired from the firm as of June 30, 2016. Mr. Chapin has worked on a broad range of financings and strategic advisory assignments totaling more than 500 billion, and was named Investment Banker of the Year by Investment Dealers Digest. Mr. Chapin was named Vice Chairman of Merrill Lynch Co., Inc. in September 2003 and was a member of the firms executive Operating Committee. From 2001 to 2003, he was Senior Vice President and Head of the Global Investment Banking division. Mr. Chapin first joined Merrill Lynch Co., Inc. in 1984 as a member of the Mergers Acquisitions group and was named a Managing Director in Corporationrationrate Banking in 1993, eventually leading the group within investment banking that provided coverage for industrial companies and actively managing the firms relationships with industrial and consumer products companies. Mr. Chapin is a member of the board of directors of publiclytraded CIRCOR International, Inc., serves on the board of trustees at Lafayette College and is a director of New Yorks Roundabout Theatre Company. Mr. Chapin holds a Bachelor of Arts degree from Lafayette College and a MBA degree from The Wharton School at the University of Pennsylvania since 2016.
| Age | 63 |
| Tenure | 8 years |
| Phone | 781 663 6900 |
| Web | https://www.perkinelmer.com |
Samuel Chapin Latest Insider Activity
Tracking and analyzing the buying and selling activities of Samuel Chapin against PerkinElmer stock is an integral part of due diligence when investing in PerkinElmer. Samuel Chapin insider activity provides valuable insight into whether PerkinElmer is net buyers or sellers over its current business cycle. Note, PerkinElmer insiders must abide by specific rules, including filing SEC forms every time they buy or sell PerkinElmer'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Samuel Chapin over six months ago Acquisition by Samuel Chapin of 10802 shares of O I subject to Rule 16b-3 |
PerkinElmer Management Efficiency
The company has Return on Asset of 0.0369 % which means that on every $100 spent on assets, it made $0.0369 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0706 %, implying that it generated $0.0706 on every 100 dollars invested. PerkinElmer's management efficiency ratios could be used to measure how well PerkinElmer manages its routine affairs as well as how well it operates its assets and liabilities.PerkinElmer has 3.92 B in debt with debt to equity (D/E) ratio of 0.65, which is OK given its current industry classification. PerkinElmer has a current ratio of 1.98, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for PerkinElmer to invest in growth at high rates of return.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Todd Sisitsky | IQVIA Holdings | 49 | |
| John Connaughton | IQVIA Holdings | 54 | |
| John Leonard | IQVIA Holdings | 62 | |
| George Llado | Charles River Laboratories | 55 | |
| Peter Neupert | Laboratory of | 65 | |
| Michael Kelly | Mettler Toledo International | 64 | |
| George Massaro | Charles River Laboratories | 73 | |
| Ronald Rittenmeyer | IQVIA Holdings | 73 | |
| Hans Bishop | Agilent Technologies | 56 | |
| Nelson Chai | Thermo Fisher Scientific | 55 | |
| Carol Burt | IQVIA Holdings | 62 | |
| Michael Berendt | Waters | 71 | |
| James Mullen | Thermo Fisher Scientific | 62 | |
| Colleen Goggins | IQVIA Holdings | 66 | |
| James Fasano | IQVIA Holdings | 50 | |
| John Danhakl | IQVIA Holdings | 64 | |
| Caspar Tudor | Waters | N/A | |
| Deborah Kochevar | Charles River Laboratories | 64 | |
| Judy Lewent | Thermo Fisher Scientific | 71 | |
| Garheng Kong | Laboratory of | 45 | |
| Jeffrey Davis | Laboratory of | 57 | |
Management Performance
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 |
PerkinElmer Leadership Team
Elected by the shareholders, the PerkinElmer's board of directors comprises two types of representatives: PerkinElmer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PerkinElmer. The board's role is to monitor PerkinElmer's management team and ensure that shareholders' interests are well served. PerkinElmer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PerkinElmer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joel Goldberg, Senior Vice President - Administration, General Counsel, Secretary | ||
| Samuel Chapin, Independent Director | ||
| Michel Vounatsos, Independent Director | ||
| James Mock, Chief Financial Officer, Senior Vice President | ||
| Sylvie Gregoire, Independent Director | ||
| Andrew Okun, Chief Accounting Officer, Vice President, Treasurer | ||
| Pascale Witz, Independent Director | ||
| Miriame Victor, Chief Commercial Officer, Senior Vice President | ||
| Peter Barrett, Independent Director | ||
| Deborah Butters, Chief Human Resource Officer, Senior Vice President | ||
| Frank Witney, Independent Director | ||
| Alexis Michas, Independent Non-Executive Chairman of the Board | ||
| Stephen Willoughby, VP ESG | ||
| Tajinder Vohra, Senior Vice President Global Operations | ||
| Prahlad Singh, Senior Vice President and President - Diagnostics | ||
| Robert Friel, Chairman, CEO and President and Member of Fin. Committee | ||
| Maxwell Krakowiak, VP CFO | ||
| Masoud Toloue, VP Diagnostics | ||
| Daniel Tereau, Senior Vice President Strategy and Business Development | ||
| Alexandros Michas, Independent Non-Executive Chairman of the Board |
PerkinElmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PerkinElmer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 22.3 B | |||
| Shares Outstanding | 126.41 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 86.25 % | |||
| Number Of Shares Shorted | 3.53 M | |||
| Price To Earning | 21.07 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |